Tolterodine tartrate【C】

Agents Used to Treat Urological Disorders
OURID1 “Uridin FC tablet” 2 mg/tab
ODETR2 “Detrusitol SR capsule” 4 mg/cap

適應症:治療伴有尿急、頻尿或急迫性尿失禁症狀的膀胱過動症。

Usual dose:

Adult: 4 mg qd, dosage may be reduced to 2 mg qd according to individual response and tolerance.

Dose adjustment:

Renal impairment (CrCl 10-30 ml/min), liver disease, concomitantly using CYP3A4 inhibitors: 2 mg qd.

Contraindication:

Gastric retention, uncontrolled narrow-angle glaucoma, urinary retention.

Precaution: history of QT prolongation, myasthenia gravis., bladder outflow obstruction.

Adverse effect:

Common: constipation, xerostomia, headache.

Serious: anaphylactoid reaction, dementia, memory impairment, angioedema.

健保使用規範:(90/7/1、93/10/1、96/4/1)

1.限符合下列診斷標準條件之一者:(1)頻尿:每天(24小時)排尿次數超過八次,並有詳實病歷紀錄;(2)急尿:病患自述經常有一種很突然、很強烈想解尿的感覺;(3)急迫性尿失禁:對於尿急的感覺無法控制,並於24小時內至少也有一次漏尿之情形。

2.不宜使用本類藥品者:(1)小兒夜尿;(2)單純性應力性尿失禁;(3)膀胱逼尿肌無反射(detrusor areflexia)或膀胱不收縮所引起之排尿困難或尿失禁之症狀。

 

 

Related Entries

(Visited 100 times, 1 visits today)